Literature DB >> 46643

Histocompatibility determinants in multiple sclerosis.

C Jersild, B Dupont, T Fog, P J Platz, A Svejgaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 46643     DOI： 10.1111/j.1600-065x.1975.tb01556.x

Source DB:  PubMed          Journal:  Transplant Rev        ISSN： 0082-5948


× No keyword cloud information.
  15 in total

Review 1.  The evidence justifying immunosuppression therapy in multiple sclerosis.

Authors:  J Mertin
Journal:  Proc R Soc Med       Date:  1977-12

2.  Multiple sclerosis: recent advances in diagnosis clinical immunology and virology.

Authors:  D W Paty
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

3.  A 'profile' of immune responsiveness in multiple sclerosis.

Authors:  G R Symington; I R Mackay; S Whittingham; J White; J D Buckley
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

4.  Two sisters with multiple sclerosis, lamellar ichthyosis, beta thalassaemia minor and a deficiency of factor VIII.

Authors:  R Capra; F Mattioli; B Kalman; N Marcianò; A Berenzi; A Benetti
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

5.  [The macrophage electrophoretic mobility LAD test - a diagnostic method for multiple sclerosis.].

Authors:  H Meyer-Rienecker; H L Jenssen; H Köhler; J K Günther
Journal:  J Neurol       Date:  1976-02       Impact factor: 4.849

6.  Analysis of allelic association between D6S461 marker and multiple sclerosis in Ashkenazi and Iraqi Jewish patients.

Authors:  Y Shinar; E Pras; I Siev-Ner; D Gamus; C Brautbar; S Israel; A Achiron
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

7.  Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

Authors:  J R Kateley; S J Bazzell
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

8.  Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.

Authors:  D C Poskanzer; P I Terasaki; L B Prenney; J L Sheridan; M S Park
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

9.  Measles virus infection and multiple sclerosis: serological studies.

Authors:  W Cendrowski; I Polna; K Nowicka
Journal:  J Neurol       Date:  1976-10-04       Impact factor: 4.849

10.  Anomalous lymphocyte-antigen reaction in relatives of multiple sclerosis patients. A study of a possible genetic factor in the disease.

Authors:  E J Field; H J Meyer-Rienecker; B K Shenton; H L Jenssen; H Köhler
Journal:  J Neurol       Date:  1977-09-12       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.